For past Congresses, use the Browse menu.
S 4152
117th Congress • 2021–2023 (Ended)

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.


Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…